Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 7/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | CHKA | P35790 | 2/20 | 0.34 |
| ▸ | EDNRB | P24530 | 1/20 | 0.34 |
| ▸ | EDNRA | P25101 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MLNR | O43193 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15424279 | 0.93 | PDK2 (0.44) | PDK2NPC1ALDH1A1LMNAMAPT | |
| SCHEMBL22891859 | 0.93 | PDK2 (0.37) | PDK2NPC1ALDH1A1LMNAMAPT | |
| SCHEMBL6372530 | 0.92 | PDK2 (0.41) | PDK2NPC1LMNAMAPTRAB9A | |
| SCHEMBL14270756 | 0.92 | PDK2 (0.41) | PDK2NPC1LMNAMAPTRAB9A | |
| SCHEMBL10029993 | 0.92 | PDK2 (0.41) | PDK2NPC1LMNAMAPTRAB9A | |
| SCHEMBL24904897 | 0.92 | PDK2 (0.41) | PDK2NPC1LMNAMAPTRAB9A | |
| SCHEMBL16158382 | 0.92 | PDK2 (0.41) | PDK2NPC1LMNAMAPTRAB9A | |
| SCHEMBL22182569 | 0.92 | PDK2 (0.41) | PDK2NPC1LMNAMAPTRAB9A | |
| SCHEMBL24904901 | 0.92 | PDK2 (0.41) | PDK2NPC1LMNAMAPTRAB9A | |
| SCHEMBL15311370 | 0.92 | PDK2 (0.41) | PDK2NPC1LMNAMAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200185604-A1 | COMPOSITION CONTAINING AMINIUM RADICAL CATION | DOW GLOBAL TECHNOLOGIES LLC | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200185604-A1 | COMPOSITION CONTAINING AMINIUM RADICAL CATION | SSR4, DRD4, SLC7A5 | PDK2 1937/4885NPC1 3987/4885ALDH1A1 1470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.